Anti-Malarial Drugs Flashcards
Malaria is a/an (acute or chronic?) infectious disease caused by 4 species of the protozoa genus _____.
Acute
plasmodia
P.________ is the most dangerous species.
Others are _______,______,_______
falciparum
P. malariae, P.ovale, P.vivax
One ______ of the world population is at risk of malaria more than 300 million cases each year. (WHO 1998).
•
fifth
Malaria kills more than a million people annually
T/F
T
Majority of mortality due to malaria are children under _____ who die cause they do not receive treatment quickly enough. (Alnwick 2000).
five
Nigeria is a malaria-endemic area
T/F
T
_______ is the principal cause of childhood mortality.
malaria
At least 20% of all childhood deaths are due directly to malaria
T/F
F(10)
_____-_____ children die from malaria each day! (FMOH)
300 – 500
________ countries accounted for 95% of malaria cases globally.
Twenty-nine
Nigeria (_____%), and _____ other countries accounted for about 51% of all cases globally. Similar stats for death
■
27
4
SUMMARY OF LIFE CYCLE of MALARIA
• Infected mosquito inject _________
• this migrate to _____ where they form ______
• these are ________ and invade _________
•________ of these cells releases ______, which (can or can’t?) infect other red cells.
• (Male or Female?) mosquito picks up _________ from infected individual
sporozoites
liver; merozoites
released; red blood cells
Rupture; merozoites; can
Female; gametocytes
Signs and symptoms of UNCOMPLICATED MALARIA
______
_______
____________ pains
_________
Malaise
_______
___________
Nightmares
Fever
Headache
Joint and body
Weakness
Vomiting
Diarrhea
Severe malaria
The presence of one or more of the following clinical or laboratory features
classifies the patient as suffering from severe malaria:
Clinical features: (WHO)
– impaired _______ or ___________
– ___________, i.e. generalized ______ so that the patient is unable walk
or sit up without assistance
– failure to ______
– multiple _______ – more than ___ episodes in ______
– deep breathing, respiratory distress (_______ breathing)
consciousness or unrousable coma
prostration; weakness
feed; convulsions
two; 24 h
acidotic
The presence of one or more of the following clinical or laboratory features
classifies the patient as suffering from severe malaria:
Clinical features: (WHO)
-__________ collapse or ______
– clinical _______ plus evidence of other vital organ dysfunction
– __________uria
– abnormal spontaneous _______
– _________ oedema (radiological)
circulatory; shock
jaundice
haemoglobin
bleeding
pulmonary
circulatory collapse or shock, in severe malaria may be characterized by systolic blood pressure < ____ mm Hg in adults
and < _____ mm Hg in children
70
50
SEVERE MALARIA
Laboratory findings:
– _____glycaemia
– (metabolic or respiratory ?) (acidosis or alkalosis?)
– severe ______cytic anaemia (Hb < 5 g/dl, packed cell volume < 15%)
hypo
metabolic; acidosis
normo
SEVERE MALARIA
Laboratory findings:
– __________uria
– hyper ___________
– hyper_________
–______ impairment (serum creatinine > 265 μmol/l).
haemoglobin
parasitaemia
lactataemia
renal
Malaria in Pregnancy
Despite _________________________, women living in endemic areas suddenly become _____________ when they become pregnant.
being clinically immune from P. falciparum malaria
susceptible to the disease
Malaria during pregnancy is characterised by very ___________ of the placenta.
heavy parasitization
Protection against P. falciparum malaria acquired prior to the first pregnancy works against the parasites
T/F
F
Protection against P. falciparum malaria acquired prior to the first pregnancy for some reason does not work against the parasites causing pregnancy-associated malaria.
Malaria in Pregnancy
The severity and prevalence of parasitaemia both rapidly decline with ______________
increasing parity
The Available Antimalarial Medicines
List them allllll
NAPS BAA (sleep and mosquitoes bite you)
The Naphthoquinolines
The Antibiotics
The Peroxides
Sulphones
The Biguanides
The Arylaminoalcohol
4-Aminoquinolines
8-Aminoquinolines
The Arylaminoalcohols
Divided into 2
________ methanols
___________ methanols
Quinoline
Phenanthrene
The Arylaminoalcohols
Quinoline methanols (______,______,______)
Phenanthrene methanols ( ________,_______)
Quinine, Quinidine, Mefloquine
Halophanthrene, Lumefantrine
The Arylaminoalcohols: Mefloquine
Aka: _______________
Mode of Action
Activity on the ____________.
Alters the binding affinity of the parasite through the _____-binding _______
4-quinoline methanol
mid- to late trophozoite
ATP; cassette transporter.
The Arylaminoalcohols: Mefloquine
Mode of Action
Is a ———- ________cide active against _____,_______,________
Blood schizonticide
P.falciparum, P.malariae, P.vivax
The Arylaminoalcohols: Mefloquine
Adverse Effects
Dizziness, nausea, vomiting, diarrhoea and abdominal pain.
Major adverse effects include ________ reactions and _______ abnormalities. However, these effects seem to be dose- related and possibly associated with prophylactic use. Concurrent use with quinine can potentiate the dose-related adverse reactions to mefloquine.
neuropsychiatric; cardiovascular
Quinoline methanols :Quinine, Quinidine
Efficacy
Is a ______ ————cide effective against P.__________
Blood schizonti
Falciparum
Quinoline methanols : Quinine, Quinidine
Mode of Action
Acts like CQ
_______________ stage of the parasite.
Mid to late trophozoite
Quinoline methanols : Quinine, Quinidine
Adverse Effects
_______,________, sometimes ______ or dizziness.
Quinine can cause severe _____tension if _____________.
May cause enhanced ______ toxicity when administered to individuals who have taken ________.
Hypoglycaemia
Tinnitus, muffled hearing; vertigo
hypo; injected too rapidly
cardiac; mefloquine
Quinidine is cardiotoxic
T/F
T
4-Aminoquinolines
________ ,________ ,_________, _________, Mepacrine (______), Pyronaridine (benzonaphthyridine)
Chloroquine
Amodiaquine
Piperaquine; Naphthoquinoline
acridine
4-Aminoquinolines
Mode of Action
Activity on _____________ stage
Prevents ____________ by ________ or _____
mid- to late trophozoite
detoxification of haem by polymerization to haemozoin or malaria pigment.
4-Aminoquinolines
Efficacy
•Marked and rapid _______cidal activity against all infections of ________________ in areas
•_______cidal against P.vivax, P.malariae and P.ovale
•Has both _________ and _________ effect.
schizonti
P.falciparum, P.malariae, P.ovale and P.vivax
Gametocyto; an antipyretic and anti inflammatory
4-Aminoquinolines
Chloroquine Adverse Effects
Nausea, vomiting, headache, GIT symptoms
_______ disturbance and ——— (commoner in ___-skinned people).
(Irreversible or reversible?) _____ impairment.
_________ has rarely, if ever, resulted from doses recommended for malaria prophylaxis. Attacks of porphyria and psoriasis may be precipitated in susceptible individuals.
visual; pruritus; dark
Irreversible; visual
Retinopathy
4-Aminoquinolines
Amodiaquine Adverse Effects
Repeated and prolonged use of AQ has been associated with __________ and __________.
However, adverse reactions to standard doses of AQ used in the treatment of malaria are generally similar to those of _________.
leucopaenia and agranulocytosis
chloroquine
Itching is more common with which
AQ or CQ
Itching is less common with AQ.
Itching is more common with CQ
8-Aminoquinolines
Examples
______,_________
Primaquine, Pamaquine
8-Aminoquinolines
Mode of Action
The mechanism of action is ____________.
unknown
8-Aminoquinolines
Efficacy
Effective against _______ forms of ___ types of malaria parasite.
For radical cure of _____________
Gametocytocidal against _______
significant blood stage activity against P. ________ (and some against asexual stages of P. ________).
intrahepatic
All types
P. V and P. O,
Falciparum
vivax; falciparum
8-Aminoquinolines
Efficacy
For radical cure of _____________
Gametocytocidal against _______
significant blood stage activity against P. ________ (and some against asexual stages of P. ________).
P. V and P. O
Falciparum
vivax; falciparum
8-Aminoquinolines
Adverse Effect
________ in individuals with _________
Haemolysis
G6PD Deficiency
Sulfones
Examples
•Sulphonamides (_____,________,_________),
•_________
sulphadoxine, sulphalene, co- trimoxazole
Dapsone